Genomic and Epigenomic Biomarkers of Toxicology and Disease. Группа авторов

Cardiothorac. Surg. 37 (3): 566–572.

      43 Sempere, L.F. and Korc, M. (2013). A method for conducting highly sensitive microRNA in situ hybridization and immunohistochemical analysis in pancreatic cancer. Methods Mol. Biol. 980: 43–59.

      44 Singh, A., Bhattacharyya, N., Srivastava, A. et al. (2019). MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis. Mol. Ther. J. Am. Soc. Gene Ther. 27 (9): 1665–1680.

      45 Tanaka, N., Toyooka, S., Soh, J. et al. (2013). Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol. Rep. 29 (6): 2169–2174.

      46 Tomasetti, M., Staffolani, S., Nocchi, L. et al. (2012). Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clin. Biochem. 45 (7-8): 575–581.

      47 Truini, A., Coco, S., Alama, A. et al. (2014). Role of microRNAs in malignant mesothelioma. CMLS 71 (15): 2865–2878.

      48 Ueno, T., Toyooka, S., Fukazawa, T., et al. (2014). Preclinical evaluation of microRNA-34b/c delivery for malignant pleural mesothelioma. Acta Med Okayama. 68 (1): 23–26.

      49 Van Roosbroeck, K., Pollet, J., and Calin, G.A. (2013). miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev. Mol. Diagn. 13 (2): 183–204.

      50 Weber, D.G., Casjens, S., Johnen, G. et al. (2014). Combination of miR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis. PloS One 9 (12): e114483.

      51 Weber, D.G., Gawrych, K., Casjens, S. et al. (2017). Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma. Dis. Markers 2017: 9280170.

      52 Wright, C.M., Kirschner, M.B., Cheng, Y.Y. et al. (2013). Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM). PloS One 8 (8): e70940.

      53 Wu, C., Jin, B., Chen, L. et al. (2013). MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma. Cell. Signal. 25 (5): 1212–1221.

      54 Zhang, P., Garnett, J., Creighton, C.J. et al. (2014). EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis. J. Pathol. 232 (3): 308–318.

      55 Zöller, M. (2013). Pancreatic cancer diagnosis by free and exosomal miRNA. World J. Gastrointest. Pathophysiol. 4 (4): 74–90.